Skip to content
Open access

Clinical differences between acute and chronic asthenic disorders: A case report

Sep 2026 · Consilium Medicum · Vol 28, pp. 634-640 · 0 citations · 19 references

TL;DR

A diagnostic framework for identifying coexisting conditions in patients with ARs is presented to enhance early disease detection and facilitate optimal pharmacological management.

Abstract

Asthenic disorders (ARs) present a significant and frequently addressed medical concern. Currently, there is no standardized classification of ARs based on severity and duration of symptoms. Acute ARs are typically linked to sudden events, infections, injuries, or vascular incidents. Symptoms manifest rapidly and typically persist for 1 to 3 months. Initial neurological symptoms may include general weakness, apathy, reduced appetite, episodic memory disturbances, challenges in information retention, reduced concentration, irritability, aggressiveness, and, less frequently, symptoms of depression or low mood. Autonomic symptoms are prominent, manifesting as fluctuations in blood pressure, tachycardia, pulse variability, various types of pain or discomfort, skin pallor or redness, sensations of heat with a normal body temperature, increased chilliness, and hyperhidrosis. Chronic ARs are associated with longstanding somatic conditions, including post-viral syndromes following SARS-CoV-2 (COVID-19) infections. A salient characteristic of chronic asthenia is its progressive nature, with symptoms persisting for more than three months. This report outlines a case involving a patient who experienced prolonged symptoms of weakness, fatigue, diminished attention span, emotional instability, various physical discomforts, gastrointestinal disturbances (such as abdominal pain, diarrhea, and dyspepsia), and severe headaches following COVID-19. These symptoms developed gradually, worsening and complicating the diagnostic process. Two years after the disease onset, the patient presented with excessive sweating, worsening weakness, persistent pain localized in the head, back, and joints, a sensation of breathlessness – particularly during exertion – and a dry cough. Following a comprehensive evaluation, the diagnosis of chronic obstructive pulmonary disease was established. During the diagnostic phase, a neuromodulatory agent (fonturacetam) was introduced to the therapeutic regimen, selected for its compatibility with the existing treatment protocol for chronic obstructive pulmonary disease. This article presents a diagnostic framework for identifying coexisting conditions in patients with ARs to enhance early disease detection and facilitate optimal pharmacological management.

Read PDF

Similar papers

Review Open access Sep 2026

CUSHING SYNDROME – DISEASE OF BOTH BODY AND MIND. LITERATURE REVIEW

Current state of knowledge on clinical features of Cushing Syndrome is presented to understand the course of CS and potential long-term consequences of the disease.

Klaudia Gogół-Fijał, Zuzanna Michalik, Klaudia Kapelka et al. · 0 citations
Review Sep 2026

Acute and chronic neurological manifestations of acute porphyria.

BACKGROUND The neurological manifestations of acute attacks and chronic symptoms were evaluated both prospectively and retrospectively in 90 patients with acute porphyria and integrated with data from previously published series. RESULTS Most acute attacks presented with a combination of abdominal pain, mild cognitiv...

E. Pischik · 0 citations
Sep 2026

Therapeutic evaluation of a classical Unani polyherbal formulation in chronic fatigue syndrome: A case report.

BACKGROUND Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) is a chronic, debilitating multisystem disorder characterized by persistent fatigue, post-exertional malaise, unrefreshing sleep, cognitive dysfunction, and impaired quality of life, with no universally effective treatment established. In Unani medi...

Ishrat Mohammed Israr, Faseeha Eram, Md Mujahid Ahmed · 0 citations
Review Oct 2026

Clinical heterogeneity and neurobiological mechanisms of asthenia

A comprehensive assessment of clinical manifestations, identification of reversible factors, and the use of evidence-based diagnostic methods can improve care for patients presenting with asthenic symptoms.

M. Tanashyan, P. Kuznetsova, S. Morozova et al. · 0 citations
Review Open access Sep 2026

Management of chronic urticaria: Current status and future prospect.

Chronic urticaria is a mast cell-driven inflammatory disease characterized by recurrent wheals, angioedema or both for more than 6 weeks, with substantial effects on sleep, quality of life, mental health and daily functioning. Type I autoallergic and type IIb autoimmune mechanisms represent major endotypes, but many pa...

A. Salman, M. Al-Ahmad, M. Al-Nesf et al. · 1 citation
Review Open access Sep 2026

Alternating hemiplegia of childhood - a systematic review.

INTRODUCTION Alternating hemiplegia of childhood (AHC) is a rare ATP1A3-related neurodevelopmental disorder characterized by recurrent hemiplegic episodes, paroxysmal neurological symptoms, and progressive motor and cognitive impairment. This systematic review summarizes current evidence on its clinical course, comorbi...

Malwina Brzozowska, Aleksandra Tobiasz, Agata Jaunich et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.